Insider Transactions in Q2 2023 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.78%
|
$144,000
$18.63 P/Share
|
|
Jun 16
2023
|
Bhaskar Chaudhuri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 16
2023
|
Rosemary A Crane Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 16
2023
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 16
2023
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 16
2023
|
Andrew D. Goldberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
-
|
|
Jun 16
2023
|
William J Phd Link Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.44%
|
-
|
|
Jun 14
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.87%
|
$162,000
$18.58 P/Share
|
|
Jun 08
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
3,100
-0.3%
|
$62,000
$20.01 P/Share
|
|
Jun 08
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.21%
|
$2,000
$20.0 P/Share
|
|
Jun 07
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-4.93%
|
$47,500
$19.34 P/Share
|
|
Jun 06
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,143
-4.06%
|
$38,574
$18.61 P/Share
|
|
May 17
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.76%
|
$120,000
$15.9 P/Share
|
|
May 11
2023
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
41,219
+27.28%
|
-
|
|
May 11
2023
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
215,576
-100.0%
|
-
|
|
May 10
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.85%
|
$144,000
$16.8 P/Share
|
|
May 01
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,841
-0.55%
|
$87,615
$15.1 P/Share
|
|
Apr 28
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
4,278
-0.4%
|
$64,170
$15.13 P/Share
|
|
Apr 21
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
2,311
-0.22%
|
$34,665
$15.03 P/Share
|
|
Apr 20
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-15.73%
|
$70,000
$14.02 P/Share
|
|
Apr 19
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.74%
|
$104,000
$13.6 P/Share
|